Poseida Therapeutics, Inc. Total Liabilities
Poseida Therapeutics, Inc. had Total Liabilities of $206.37 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-11-07
- 2024-09-30: Liabilities $206.37M.
- 2024-06-30: Liabilities $237.87M.
- 2024-03-31: Liabilities $177.99M.
- 2023-12-31: Liabilities $170.18M.
| Period end | Liabilities |
|---|---|
| 2024-09-30 | $206.37M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $237.87M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $177.99M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $170.18M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $178.59M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $145.91M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $156.06M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $164.24M 10-K · filed 2024-03-07 |
| 2022-09-30 | $164.17M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $139.66M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $144.45M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $113.10M 10-K · filed 2023-03-09 |
| 2021-09-30 | $111.78M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $112.53M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $105.85M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $109.52M 10-K · filed 2022-03-10 |
| 2020-09-30 | $109.33M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $105.34M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $74.33M 10-K · filed 2021-03-11 |